A detailed history of Oakworth Capital, Inc. transactions in United Therapeutics Corp stock. As of the latest transaction made, Oakworth Capital, Inc. holds 1,111 shares of UTHR stock, worth $400,926. This represents 0.03% of its overall portfolio holdings.

Number of Shares
1,111
Previous 1,111 -0.0%
Holding current value
$400,926
Previous $353,000 12.75%
% of portfolio
0.03%
Previous 0.03%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 05, 2022

BUY
$174.81 - $241.14 $194,213 - $267,906
1,111 New
1,111 $262,000
Q1 2018

May 09, 2018

SELL
$107.21 - $151.94 $6,861 - $9,724
-64 Closed
0 $0
Q4 2017

Jan 22, 2018

SELL
$118.58 - $151.28 $52,768 - $67,319
-445 Reduced 87.43%
64 $8,000
Q3 2017

Nov 08, 2017

BUY
$114.6 - $136.81 $58,331 - $69,636
509
509 $67,000

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $16.4B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Oakworth Capital, Inc. Portfolio

Follow Oakworth Capital, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oakworth Capital, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Oakworth Capital, Inc. with notifications on news.